- 1Graduate Management Unit, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China
- 2School of Pharmacy, Second Military Medical University, Shanghai, China
- 3Department of Orthopedics, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China
- 4China-South Korea Bioengineering Center, Shanghai, China
- 5Orthopedic Basic and Translational Research Center, Jiangyin, China
This article has been retracted. Please follow the link to the full retraction notice for details.
Citation: Xin Z, Jin C, Chao L, Zheng Z, Liehu C, Panpan P, Weizong W, Xiao Z, Qingjie Z, Honggang H, Longjuan Q, Xiao C and Jiacan S (2021) Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5. Front. Pharmacol. 12:605592. doi: 10.3389/fphar.2021.605592
Received: 15 September 2020; Accepted: 08 February 2021;
Published: 29 March 2021; Retracted: 19 February 2025.
Edited by:
Patrizia Ballerini, University of Studies G. d’Annunzio Chieti and Pescara, ItalyReviewed by:
Satish Ramalingam, SRM Institute of Science and Technology, India